Clinical Trial: A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526116) titled 'A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults' on April 06.

Brief Summary: This clinical study will evaluate the study drug, REGN22044, in healthy participants. REGN22044 has not previously been studied in humans.

The purpose of this study is to learn:

* What side effects may happen when REGN22044 is taken

* How much of REGN22044 is in the blood at different times

* Whether the body makes antibodies against REGN22044 (which could make the drug less effective or could lead to side effects)

Study Start Date: May 07

Study Type: INTERVENTIONAL

Condition...